SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Landec Corporation on May 23, 2011. The filing addresses Item 5.02 regarding compensatory arrangements for the fiscal year 2012. The Company operates subsidiaries including Apio, Inc. and Lifecore Biomedical, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the approval of a cash bonus plan structure rather than reporting financial performance results.
Material Changes
On May 23, 2011, the Board of Directors approved a new cash bonus plan for the 2012 fiscal year. This represents a change in the compensatory structure for employees across the Company and its subsidiaries.
Guidance, Outlook, and Management Commentary
- Bonus Structure: Cash bonuses are tied to the achievement of revenue and controllable income targets for the Company, Apio, and Lifecore individually.
- Calculation Method: Bonuses are calculated by multiplying a percentage of base salary by the percentage of the performance target achieved.
- Maximum Payouts: The percentage of base salary used for maximum bonus calculations ranges from 83% to 104% for executive officers and 19% to 87% for other employees.
- Eligibility: Participants must be employed at the end of fiscal year 2012 to receive a bonus.
- Payment Timing: Payments will be made in a single lump sum as soon as practicable after the end of the 2012 fiscal year.
Investor Verification Checklist
- Verify the specific revenue and controllable income targets set for the 2012 fiscal year, as these are not disclosed in this filing.
- Confirm the total aggregate cash bonus amount allocated under the Plan.
- Review the Company's 2012 fiscal year-end date to determine the exact eligibility cutoff.
- Assess the impact of the new bonus structure on future operating expenses and cash flow projections.